Women in Science and Technology: Why in the US?
Date and time
Location
Massachusetts Institute of Technology. Kirsch Auditorium
32 Vassar St Building 32. Room 123 Cambridge , MA 02139Description
We will discuss the role of women in science and technology with an exceptional panel of speakers from industry and academia. In an interactive forum, our 5 panelist will share their experiences regarding opportunities and challenges in their professional careers in the US and abroad.
Free registration is required. Please click "Register" (above) to sign up. The program will be in English and refreshments will be served.
We look forward to seeing you!
The ECUSA-Boston Team.
Panelists
Belen Garijo, MD. Member of the Executive Board. CEO Merck Healthcare
- Public Affairs & Corporate Responsibility
-
L’Oréal SA, Member of the Board of Directors
-
Banco Bilbao Vizcaya Argentaria S.A., Member of the Board of Directors
-
PhRMA (Pharmaceutical Research and Manufacturers of America), Member of the Board
Santiago Arroyo, MD, PhD. Chief Medical Officer. Boston Pharmaceuticals
Santiago is the Chief Medical Officer of Boston Pharmaceuticals. Santiago has over twenty years of experience leading clinical development programs in the pharmaceutical industry across multiple therapeutic areas and as an academic principal investigator conducting clinical trials. Following a successful academic career, Santiago joined the pharmaceutical industry and moved rapidly into positions of increasing responsibility including Clinical Head of Neurology at Eisai Medical Research (NJ) where he led the successful filing of rufinamide for children Lennox-Gastaut syndrome. He was then appointed Therapeutic Head for Neurosciences in Discovery Medicine at Bristol Myers Squibb (Princeton, NJ). Afterwards, he joined Pfizer where he had successive roles as VP Psychiatry Clinical Head (Groton, CT), VP Clinical Head for Neusentis (Pain and Regenerative Medicine) (Cambridge, UK) and Senior VP Clinical Research Head for Pharmatherapeutics and Biotherapeutics (New York, NY).
Santiago was a Clinical Fellow and Instructor in Neurology at the Johns Hopkins Hospital and Medical School. He was then appointed Director of the Epilepsy Program and Senior Staff Neurologist at the Hospital Clinic de Barcelona. Later on, he was appointed Associate Professor of Neurology; Director, Adult Epilepsy Program and Electroencephalography Laboratory; Staff Neurologist at Froedtert Hospital; and Staff Neurologist at Children’s Hospital of Wisconsin.
Santiago received his M.D. from the Facultad de Medicina, Universidad Autonóma de Madrid. This was followed by an Internship and Neurology Residence at the Hospital Clínico de Madrid. He obtained his doctoral degree from the Universidad de Barcelona
Pilar Alcaide,PhD. Associate Professor. Tufts University School of Medicine
Dr. Alcaide received her PhD in Molecular Biology from Universidad Autonoma of Madrid, Spain, where she studied the immunological aspects of Trypanosoma cruzi infection, the protozoan parasite that causes Chagas disease. As a recipient of a Fulbright postdoctoral fellowship, Dr. Alcaide trained in vascular biology in the Vascular Research Division, Brigham and Women’s hospital, Boston, where she studied the mechanisms regulating immune cell trafficking to sites of inflammation. After completion of her postdoctoral research training, Dr. Alcaide was appointed to Instructor of Pathology at Harvard Medical School, where she successfully competed for a “Pathway to Independence NIH K99/R00 award”. In September 2011, Dr. Alcaide joined the faculty at the Molecular Cardiology Research Institute at Tufts Medical Center, Boston, and started her independent research program as an Assistant professor, and in May of 2016, she was appointed to Associate Professor of the Department of Integrative Physiology and Pathobiology at Tufts University School of Medicine.
Dr. Alcaide’s research focuses in understanding the role of T lymphocytes in heart inflammation and their impact in the progression of heart failure, with the ultimate goal of unveiling new pathways that can potentially be targeted in therapeutic useful ways. Her research has been constantly funded by grants from the American Heart Association (AHA), the National Heart Lung and Blood Institute (NHLBI) and several other private foundations, and her trainees have received multiple awards from the AHA, the Federation of American Societies of Experimental Biology (FASEB), and the American Society of Investigative Pathology (ASIP). Dr. Alcaide serves in NIH study sections, including the Mentored Transition to Independence (MTI), which discusses scientific applications of the new upcoming independent research scientists. Dr. Alcaide is also a member of the AHA Early Career Committee, with the mission of promoting career development of young scientists, and a participant mentor of the ASIP mentoring program. Dr. Alcaide also served as the chair of the Work- Life balance committee during her tenure at Tufts Medical Center, where she was a member of the Women in Medicine and Science committee. Her role as a chair was to bring advocacy and resources to women scientists to support their full engagement of their personal and professional lives
I am the Director of the Drug Hypersensitivity and Rapid Desensitization Center for inpatients and outpatientsat Brigham and Women’s Hospital and perform evaluation of about 800 patients per year with drug adverse reactions, providing diagnostic and treatment options, including high risk desensitization procedures. I am the PI of various clinical trials – IgA deficiency on patients receiving IVIG, leukotriene measurement in patients with mastocytosis, bone loss in patients with mastocytosis, and MATA grass on immunotherapy for grass pollen allergies.
As a teacher, I give formal and informal rounds daily while attending and four times a week while on the outpatient duty. I teach Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center residents, students from Harvard Medical School, and fellows in training from the Allergy and Clinical Immunology training programs at Brigham and Women’s Hospital, Children’s Hospital, and Massachusetts General Hospital. I participate in the PD (Patient Doctor) 2 Preceptor-Student Project and formally precept two students per year in weekly 2-hour sessions. I am a mentor for the Career Development Project at the BWH and direct one mentee for three years. In the last ten years, I have directed an Introductory Course for Allergy Fellows, held at the Brigham and Women’s Hospital. The course provides an immersion in basic and clinical allergy and immunology with 25-30 core curriculum topics. The lectures are given by faculty from Brigham and Women’s Hospital including myself, Beth Israel Deaconess Medical Center, Tufts, Massachusetts General Hospital and The Children’s Hospital. Attendance at the Course has included all the Allergy Fellows in Training for the Partners hospitals and other major hospitals in Boston. Written evaluations provided yearly by participants indicate outstanding reviews.
As a researcher, I have my own research laboratory and work on mast cell inhibitory mechanisms. I cloned the gene for LilRB4, which belongs to a family of inhibitory receptors expressed in mast cells, macrophages and NK cells. I elucidated one ligand for LilRB4, the blood vessel integrin avb3 and demonstrated that the interaction between LilRB4 and avb3 is functional, in that avb3 inhibits the antigen-induced bone marrow-derived mast cell activation and release of mediators. I have now turned my efforts to the study of an inhibitory mast cell-dependent process that leads to temporary cell desensitization and unresponsiveness to antigen. I created a cellular model for mast cell IgE-dependent temporary desensitization and provided the first molecular target of this phenomenon, the signal transduction and activator of transcription factor 6 (STAT6). The model has now provided evidence for inhibition of calcium flux during desensitization and blocking the internalization of the FceR1 receptor.
Eva Ponce,PhD. Executive Director, MITxMicroMaster´s in SupplyChain Management;
Research Associate. Massachusetts Institute of Technology
Eva Ponce is the Executive Director of the Supply Chain Management MicroMaster’s Program and a Research Associate at the MIT Center for Transportation & Logistics. She has coordinated the online MITx courses in Supply Chain Management (CTL.SC1x), with more than 30,000 students. Her current research focus is the design of urban distribution models (freight deliveries), with special focus on omni-channel. She also leads research initiatives on Reverse Logistics and Closed-Loop Supply Chains.
Dr. Ponce has over fifteen years of experience in teaching and researching in supply chain management and quantitative models for industrial engineering. In 2008, she received her tenure as an Associate Professor in Supply Chain Management and Logistics at the School of Industrial Engineering of the Universidad Politécnica de Madrid (UPM).
Dr. Ponce received her PhD in Industrial Engineering from Carlos III University of Madrid in 2002. Her dissertation has received two awards with special distinction. In 2000, she was granted with a pre-doctoral research stay in the Hass School of Business, University of California, and in 2011, she was a visiting professor at MIT CTL. She has an active publication record, including journal papers, conference proceedings and refereed abstracts.
When
September 8th 2016
6:15 pm
Massachusetts Institute of Technology. Kirsch Auditorium, 32 Vassar St.
Cambridge, MA 02139
Building 32. Room 123
https://whereis.mit.edu/?go=32
Sponsored by
Presented by
